Mammography stages of change in middle-aged women with schizophrenia: An exploratory analysis

BMC Psychiatry

Volumn 6, Issue , 2006, Pages

  Lindamer, Laurie A ^a,b,c   Wear, Emily ^a   Sadler, Georgia Robins ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO ILLNESS; BREAST CANCER; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GROUPS BY AGE; HEALTH BELIEF MODEL; HIGH RISK POPULATION; HUMAN; KNOWLEDGE; MAMMOGRAPHY; MEDICAL RESEARCH; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; SAMPLE SIZE; SCHIZOPHRENIA; STATISTICAL ANALYSIS; VALIDATION STUDY;

ADULT; BREAST NEOPLASMS; FEMALE; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; PSYCHOMETRICS; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL CONDITIONS;

EID: 33751019662     PISSN: 1471244X     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-6-49     Document Type: Article

References (66)

1. National Cancer Institute: Cancer Progress Report 2001 2001 [http://progressreport.cancer].
2. Schootman M, Jeffe D, Reschke A, Aft R: The full potential of breast cancer screening use to reduce mortality has not yet been realized in the United States. Breast Cancer Res Treat 2004, 2815-03:1-4.
3. Kriclar A. Farac K, Smith D, Sweenly A, McCrodie M, Armstrong BK: Breast cancer in South Wales in 1972-1995: Tumor size and the impact of mammographic screening. Int J Cancer 1999, 81:877-880.
4. McCann J, Stockton D, Day N: Breast cancer in East Anglia: The impact of the breast screening programme on stage at diagnosis. J Med Screen 1998, 5:42-48.
5. Schouten LS, De Rijke J M, Schlangen JT, Verbeek AL: Evaluation of the effect of breast cancer screening by record linkage with the cancer registry. J Med Screen 1998, 5:37-41.
6. U.S. Department of Health and Human Services - Public Health Service: Healthy People 2000 - National Health Promotion and Disease Prevention Objectives Washington, DC: U.S. Government Printing Office; 1990.
7. Calle EE, Flanders WD, Thun MJ, Martin LM: Demographic predictors of mammography and pap smear screening in US women. Am J Public Health 1993, 83:53-60.
8. Sadler GR, Huang J, Padden C, Elion L, Galey T, Gunsauls DC, Brauer B: Bringing health care information to the deaf community. J Cancer Educ 2001, 16: 105-108.
9. Legg JS,Clement DG, White KR: Are women with self-reported cognitive limitations at risk for underutilization of mammography? J Health Care Poor Underserved 2004, 15:688-702.
10. Lindamer LA, Buse DC, Auslander A, Unutzer J, Bartels SJ, Jeste DV: A comparison of gynecological variables and services use in older women with and without schizophrenia. Psychiatr Serv 2003, 54:902-904.
11. Dickerson FB, Pater A, Origoni AE: Health behaviors and health status of older women with schizophrenia. Psychiatr Serv 2002, 53:882-884.
12. Rimer BK, Resch N, King E, Ross E, Lerman C, Boyce A, Kessler H, Engstrom PF: Multistrategy health education program to increase mammography use among women ages 65 or older. Public Health Rep 1992, 107:369-380.
13. Lantz PM, Stencil D, Lippert MT, Beversdorf S, Jaros L, Remington PL: Breast and cervical cancer screening in a low-income managed care sample: the efficacy of physician letters and phone calls. Am J Public Health 1995, 85:834-836.
14. Ettigi P, Lai S, Friesen H: Prolactin, phenothiazine, admission to mental hospital and carcinoma of the breast. Lancet 1973, 11:266-267.
15. Masterson E, O'Shea B: Smoking and malignancy in schizophrenia. Br J Psychiatry 1984, 145:429-432.
16. Baldwin JA: Schizophrenia and physical disease. Psychol Med 1979, 9:611-618.
17. Brugmanns J, Verbruggen R, Dom J: Prolactin, phenothiazine, admission to mental hospital and carcinoma of the breast. Lancet 1973, 11:502-503.
18. Halbreich U, Shen J, Panaro V: Are chronic psychiatric patients at increased risk for developing breast cancer. Am J Psychiatry 1996, 153:559-560.
19. Lichtermann D, Ekelund J, Pukkala E, Tanskanen A, Lonnqvist J: Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry 2001, 58:573-578.
20. Oksbjerg IDS, Munk LT, Mellemkiaer L, Johansen C, Mortensen PB: Schizophrenia and the risk for breast cancer. Schizophr Res 2003, 62:89-92.
21. Barak Y, Achiron A, Mandel M, Mirecki I, Aizenberg D: Reduced cancer incidence among patients with schizophrenia. Cancer 2005, 104:2817-2821.
22. Brown S, Birtwistle J, Roe L, Thompson C: The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999, 29:697-701.
23. American Cancer Society: Cancer Facts and Figures Atlanta, GA. The Society; 2001.
24. Wang PS, Walker AM, Tsuang MT, Orav EJ, Glynn RJ, Levin R, Avorn J: Dopamine antagonists and the development of breast cancer. Arch Gen Psychiatry 2002, 59:1147-1154.
25. Carney CP, Allen J, Doebbeling BN: Receipt of clinical preventive medical services among psychiatric patients. Psychiatr Serv 2002, 53:1028-1030.
26. Rosenstock IM: Why people use health services. Memorial Fund Quarterly 1966, 44:94-121.
27. Prochaska JO, Velicer WF: The transtheoretical model of health behavior change. American journal of Health Promotion 1997, 12:38-48.
28. Becker MH: The health belief model and personal health behavior. Health Education Monthly 1974, 2:324-SO8.
29. Janz NK, Becker MH: The health belief model: A decade later. Health Educ Q 1984, 11:1-47.
30. Rutledge DN, Hartmann WH, Kinman PO, Winfeld AC: Exploration of factors affecting mammography behaviors. Prev Med 1988, 17:412-422.
31. Aiken LS, West SG, Woodward CK, Reno RR: Health beliefs and compliance with mammography screenign reccomendations in asymptomatic females. Health Psychol 1994, 13:122-129.
32. Champion VL Compliance with guidelines for mammography screening. Cancer Detect Prev 1992, 16:253-258.
33. Burack RC, Liang J: The acceptance and completion of mammography by older Black women. Am J Public Health 1989, 79:721-726.
34. Calnan M: The health belief model and participation in programs for the early detection of breast cancer. A comparative analysis. Social Science Medicine 1984, 19:823-830.
35. Champion VL: The relationship of selected variables to breast cancer detection behaviors in women 35 and older. Oncol Nurs Forum 1991, 18:733-739.
36. Champion VL: Beliefs about breast cancer and mammography by behavioral stage. Oncol Nurs Forum 1994, 21:1009-1014.
37. Fajardo UL, Saint-Germain M, Meaken TJI, Rose C, Hillman BJ: Factors influencing women to undergo screening mammography. Radiology 1992, 184:59-63.
38. Fulton JP, Buechner JS, Scott HD: A study guided by the Health Belief Model of the predictors of breast cancer screening of women ages 40 or older. Public Health Rep 1991, 106.410-420.
39. Murray M, McMillan C: Health beliefs, locus of control, emotional control and women's cancer screening beliefs. Br J Clin Psychol 1993, 32:87-100.
40. Rimer BK, Trock B, Engstrom PF, Lerman C, King E: Why do some women get regular mammograms? American journal of Preventative Medicine 1991, 7:69-74.
41. Stein JA Fox SA, Murata PJ, Morisky DE: Mammography usage and the health belief model. Health Educ Q 1992, 19:447-462.
42. Rimer BK, Keintz MK, Kessler HB, Engstrom PF, Rosan JR: Why women resist screening mammography: Patient-related barriers. Radiology 1989, 172:243-246.
43. Rakowski W, Dube CE, Marcus BH, Prochaska JO, Velicer WF, Wayne F, Abrams DB: Assessing elements of women's decisions about mammography. Health Psychol 1992, 11:111-118.
44. Rakowski W, Ehrich B, Goldstein MG, Rimer BK, Pearlman DN, Clark MA, Velicer WF, Woolverton HI: Increasing mammography among women aged 40-74 by use of a stage-matched, tailored intervention. Preventative Medicine 1998, 27:748-756.
45. Rakowski W, Fulton JP, Feldman JR. Women's decision about mammography. A replication of the relationship between stages of adoption and decisional balance. Health Psychol 1993, 12:209-214.
46. Skinner CS, Arfken CL, Sykes RK: Knowledge, perceptions, and mammography stage of adoption among older urban women. Am J Prev Med 1998, 14:54-63.
47. Crane LA Leakey TA, Rimer BK, Wolfe P, Woodworth MA, Warnecke RB: Effectiveness of a telephone outcall intervention to promote screening mammography among low-income women. Prev Med 1998, 27:S39-S49.
48. Crane LA Leakey TA, Ehrsam G, Rimer BK, Warnecke RB: Effectiveness and cost-effectiveness of multiple outcalls to promote mammography among low-income women. Cancer Epidemiol Biomarkers Prev 2002, 9:923-931.
49. Rakowski W, Stoddard AM, Rimer BK, Fox SA, Andersen MR, Urban N, Lane DS, Costanza ME: Confirmatory analysis of opinions regarding the pros and cons of mammography. Health Psychol 1997, 16:433-441.
50. Carey KB, Maisto SA, Carey MP, Purnine DM: Measuring readiness-to-change substance misuse among psychiatric outpatients: 1. Reliability and validity of self-report measures. J Stud Alcohol 2001, 62:79-88.
51. Addington J, el-Guebaly N, Duchak V, Hodgins D: Using measures of readiness to change in individuals with schizophrenia. Journal of Drug and Alcohol Abuse 1991, 25:151-161.
52. Velasquez MM, Carbonari JP, DiClemente CC: Psychiatric severity and behavior change in alcoholism: The relation of the trantheoretical model variables to psychiatric distress in dually diagnosed patients. Addict Behav 1999, 24:481-496.
53. Esterberg ML, Compton MT: Smoking behavior in persons with a schizophrenia-spectrum disorder. a qualitative investigation of the transtheoretical model. Soc Sci Med 2005, 61:293-303.
54. Bellack AS, DiClemente CC: Treating substance abuse among patients with schizophrenia. Psychiatr Serv 1999, 50:75-80.
55. Carey MP, Casey KB, Meisler AW: Psychiatric symptoms in mentally ill chemical abusers. Journal of Nervous & Mental Disease 1991, 179:136-138.
56. Owen RR, Fischer EP, Booth BM, Cuffel BJ: Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatr Serv 1996, 47:853-858.
57. Bartels SJ, Teague GB, Drake RE, Clark RE, Bush PW, Noordsy DL: Substance abuse in schizophrenia: Service utilization and costs. Journal of Nervous & Mental Disease 1993, 181:227-232.
58. Folsom DP, Hawthorne W, Lindamer L, Gilmer T, Bailey A, Golshan S, Garcia P, Unutzer J, Hough R, Jeste DV: Prevalence and risk factors for homelessness and utilization of mental health services among 10,340 patients with serious mental illness in a large public mental health system. Am J Psychiatry 2005, 162:370-376.
59. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Text Revision Four edition. Washington, DC: American Psychiatric Association; 2000.
60. Kay S, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bug 1987 13:261-276.
61. Skinner CS, Strecher VJ, Hospers H: Physicians' recommendations for mammography. Do tailored messages make a difference? Amercian Journal of Public Health 1994, 84:43-49.
62. American Cancer Society: Breast Cancer Facts and Figures 2001-2002. No. 8610.01R 2002.
63. Sadler GR, Gunsauls DC, Huang J, Padden C, Elion L, Galey T, Brauer B, Ko CM: Bringing breast cancer education to deaf women. J Cancer Educ 2001, 16:225-228.
64. Sadler GR, Thomas AG, Dhanjal SK, Gebrekristos B, Wright FA: Breast cancer screening adherence in Africa-American Women: Black cosmetologists promoting health. Cancer Supplement 1998, 83:1836-1839.
65. Sadler GR, Thomas AG, Yen JY, Dhanjal SK, Ko CM, Tran CH, Wang K: Breast cancer education program based in Asian grocery stores. J Cancer Educ 2000, 15:173-177.
66. Steiner JL, Hoff RA, Moffett C, Reynolds H, Mitchell M, Rosenheck R: Preventive health care for mentally ill women. Psychiatr Serv 1998, 49:696-698.